Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis

New England Journal of Medicine

Volumn 353, Issue 4, 2005, Pages 369-374

  Kleinschmidt DeMasters, B K ^a   Tyler, Kenneth L ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA1A INTERFERON; CALCIUM; CITALOPRAM; DONEPEZIL; GALANTAMINE; MAGNESIUM; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; NATALIZUMAB; PARACETAMOL; ROFECOXIB; TAMSULOSIN; TIZANIDINE; TRAMADOL; VIRUS DNA; VITAMIN B GROUP; ALPHA4 INTEGRIN; BETA INTERFERON; IMMUNOLOGICAL ADJUVANT;

APHASIA; ARTICLE; ASTROCYTE; AUTOPSY; BLADDER DYSFUNCTION; BRAIN INJURY; CASE REPORT; CAUSE OF DEATH; CEREBROSPINAL FLUID; CLINICAL TRIAL; DEPRESSION; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; ELECTROMYOGRAPHY; FEMALE; HEMIPARESIS; HEMISPHERE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; JC VIRUS; MICROSCOPY; MULTIPLE SCLEROSIS; NERVE CONDUCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; TISSUE SECTION; TREATMENT FAILURE; ADULT; BRAIN; CHEMICALLY INDUCED DISORDER; FATALITY; IMMUNOLOGY; ISOLATION AND PURIFICATION; LEUKOENCEPHALOPATHY; OPPORTUNISTIC INFECTION; PATHOLOGY; VIROLOGY;

ADJUVANTS, IMMUNOLOGIC; ADULT; ANTIBODIES, MONOCLONAL; BRAIN; CEREBROSPINAL FLUID; FATAL OUTCOME; FEMALE; HUMANS; INTEGRIN ALPHA4; INTERFERON-BETA; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; OPPORTUNISTIC INFECTIONS;

EID: 22844439662     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa051782     Document Type: Article

References (13)

1. Koralnik IJ. New insights into progressive multifocal leukoencephalopathy. Curr Opin Neurol 2004;17:365-70.
2. Van Assche G, Van Ranst M, Sciot R, et al. Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N Engl J Med 2005;353:362-8.
3. Knowles WA, Pipkin P, Andrews N, et al. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol 2003;71:115-23.
4. Stolt A, Sasnauskas K, Koskela P, Lehtinen M, Dillner J. Seroepidemiology of the human polyomaviruses. J Gen Virol 2003;84:1499-504.
5. Gasnault J, Kahraman M, de Goer de Herve MG, Durali D, Delfraissy JF, Taoufik Y. Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal multifocal leukoencephalopathy. AIDS 2003;17:1443-9.
6. Goldberg SL, Pecora AL, Alter RS, et al. Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab. Blood 2002;99:1486-8.
7. Imperato AK, Bingham CO III, Abramson SB. Overview of benefit/risk of biological agents. Clin Exp Rheumatol 2004;22:Suppl 35:S108-S114.
8. Miller DH, Khan OA, Sheremata WA, et al. A controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 2003;348:15-23.
9. Ghosh S, Goldin E, Gordon FH, et al. Natalizumab for active Crohn's disease. N Engl J Med 2003;348:24-32.
10. Rice GPA, Hartung H-P, Calabresi PA. Anti-alpha4 integrin therapy for multiple sclerosis: mechanisms and rationale. Neurology 2005;64:1336-42.
11. 4 Integrins as therapeutic targets in autoimmune disease. N Engl J Med 2003;348:68-72.
12. Yednock TA, Cannon C, Fritz LC, Sanchez-Madrid F, Steinman L, Karin N. Prevention of experimental autoimmune encephalomyelitis by antibodies against α4β1 integrin. Nature 1992;356:63-6.
13. Kent SJ, Karlik SJ, Cannon C, et al. A monoclonal antibody to alpha 4 integrin suppresses and reverses active experimental allergic encephalomyelitis. J Neuroimmunol 1995;58:1-10.